Journal of Clinical Oncology
Tissue platinum concentrations linked to response in NSCLC
(HealthDay) -- For patients with non-small-cell lung cancer (NSCLC) who undergo neoadjuvant platinum-based chemotherapy, tissue platinum concentrations correlate positively with improved outcome, according ...
Cancer
Aug 14, 2012 |
not rated yet |
0
Blood test could guide treatment for kidney cancer
A common enzyme that is easily detected in blood may predict how well patients with advanced kidney cancer will respond to a specific treatment, according to doctors at Duke Cancer Institute.
Cancer
Aug 13, 2012 |
not rated yet |
0
Study links age, insurance, but not race, to chemo rates
(HealthDay) -- For women with breast cancer, disease characteristics correlate significantly with chemotherapy receipt, with no indication of racial barriers to treatment, according to a study published online ...
Cancer
Aug 10, 2012 |
not rated yet |
0
Nonoperative approach feasible in advanced colon cancer
(HealthDay) -- Treating patients with surgically unresectable metastatic colon cancer and an asymptomatic intact primary tumor with bevacizumab and infusional fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) ...
Cancer
Aug 09, 2012 |
not rated yet |
0
Bortezomib beneficial in graft-versus-host disease prophylaxis
(HealthDay) -- Patients with hematologic malignancies undergoing an HLA-mismatched unrelated donor (MMUD) reduced-intensity conditioning (RIC) hematopoietic stem cell transplantation (HSCT) may benefit from ...
Cancer
Aug 08, 2012 |
not rated yet |
0
Taxane-induced neuropathy not tied to breast cancer outcome
(HealthDay) -- For patients with operable breast cancer, peripheral neuropathy due to adjuvant taxane therapy does not correlate with improved outcomes, according to research published online July 30 in the ...
Cancer
Aug 02, 2012 |
not rated yet |
0
Scientists identify genetic drivers of leukaemia
(Medical Xpress) -- Scientists at Newcastle University have discovered three key genetic errors which can dictate how adult patients develop leukaemia and respond to treatment and could help doctors adapt ...
Cancer
Aug 02, 2012 |
5 / 5 (2) |
0
Active surveillance up in multidisciplinary prostate CA care
(HealthDay) -- Men with low-risk prostate cancer are more likely to pursue active surveillance when seen at a multidisciplinary prostate cancer clinic rather than when they see individual specialists in sequential ...
Cancer
Aug 01, 2012 |
not rated yet |
1
HPV test beats pap long-term: study
(HealthDay) -- Testing for HPV, the human papillomavirus linked to cervical cancer, can predict which women will stay cancer-free for a decade or more, a new study shows.
Cancer
Jul 30, 2012 |
not rated yet |
0
|
Study supports longer scope intervals post-polypectomy
(HealthDay) -- People who have had a colonoscopy during which a high-risk potentially cancerous polyp was removed may not need another colonoscopy for five years, German researchers report.
Cancer
Jul 24, 2012 |
not rated yet |
0
Bortezomib ups response, survival in multiple myeloma
(HealthDay) -- For patients with newly diagnosed multiple myeloma (MM), induction treatment with a combination of bortezomib, doxorubicin, and dexamethasone (PAD) followed by bortezomib maintenance therapy ...
Cancer
Jul 23, 2012 |
not rated yet |
0
Benefits of prostate-specific antigen testing remain unclear
(HealthDay) -- It remains unclear whether the benefits of prostate-specific antigen (PSA) testing outweigh the harms, but evidence suggests that men with a longer life expectancy may benefit from testing, ...
Cancer
Jul 20, 2012 |
not rated yet |
3
|
Improved survival for patients with chronic blood diseases
(Medical Xpress) -- New research from Karolinska Institutet shows that the survival for patients with chronic myeloproliferative diseases has improved in recent decades. This is despite the fact that no targeted drugs have ...
Cancer
Jul 17, 2012 |
not rated yet |
0
Expert panel suggests PSA test may benefit some men
(HealthDay) -- Men with a life expectancy of more than 10 years should talk with their doctor about getting a prostate-specific antigen (PSA) test for prostate cancer, an expert panel recommends.
Cancer
Jul 16, 2012 |
not rated yet |
1
Obesity may affect response to breast cancer treatment: study
Women who are obese continue to have higher levels of oestrogen than women of normal weight even after treatment with hormone-suppressing drugs, raising the possibility that they might benefit from changes to their treatment.
Cancer
Jul 16, 2012 |
not rated yet |
0
|
